Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple‐Cell 2D Atherosclerosis Model-Reference-Cited by-同舟云学术

Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple‐Cell 2D Atherosclerosis Model

Published:2022-02-13 Issue:13 Volume:18 Page:2105915
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Jebari‐Benslaiman Shifa¹,Uribe Kepa B.²,Benito‐Vicente Asier¹,Galicia‐Garcia Unai³,Larrea‐Sebal Asier³,Santin Izortze⁴⁵⁶,Alloza Iraide⁵,Vandenbroeck Koen⁵,Ostolaza Helena¹,Martín César¹^ORCID

Affiliation:

1. Biofisika Institute (UPV/EHU CSIC) and Department of Biochemistry and Molecular Biology University of the Basque Country UPV/EHU Leioa 48940 Spain

2. Center for Cooperative Research in Biomaterials (CIC biomaGUNE) Basque Research and Technology Alliance (BRTA) San Sebastián 20014 Spain

3. Fundación Biofisika Bizkaia and Biofisika Institute (UPV/EHU, CSIC) Leioa 48940 Spain

4. Department of Biochemistry and Molecular biology University of the Basque Country UPV/EHU Leioa 48940 Spain

5. Biocruces Bizkaia Health Research Institute Barakaldo 48903 Spain

6. CIBER (Centro de Investigación Biomédica en Red) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Instituto de Salud Carlos III Spain

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202105915

Reference90 articles.

1. World Health Organization Cardiovascular Diseases (CVDs)2020.

2. The immune system in atherosclerosis

3. Inflammation in Atherosclerosis

4. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?

5. Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Computational and Biological Hemodynamic Approaches to Improve Modeling of Atherosclerotic Arteries;Advanced Science;2024-05-05

2. Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease;Current Problems in Cardiology;2024-04

3. VCAM-1-Targeted Nanoparticles to Diagnose, Monitor and Treat Atherosclerosis;Nanomedicine;2024-03-22

4. Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers;Exploration;2023-12-07

5. Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets;Expert Opinion on Therapeutic Targets;2023-11-28